Human Rights and Global Pharma Converge

  • The Hon Michael Kirby AC CMG

Abstract

In this article, based on the annual public oration of the Australian Centre for Health Law Research at QUT, Michael Kirby explores the interaction between the discovery of life saving and health preserving pharmaceuticals and international intellectual property (IP) law. He explains the investigation of this topic in a number of transnational bodies in which he has worked. He outlines the specific benefits of antiretroviral medicines for treatment of HIV causing AIDS and HCV (Hepatitis C). He explains the advent of the United Nations Sustainable Development Goals in 2015 and his participation in a High Level Panel created by the UN Secretary General to ensure their attainment. The article closes with some suggested further directions in international IP law and health access.

Published
Jan 25, 2019
How to Cite
KIRBY AC CMG, The Hon Michael. Human Rights and Global Pharma Converge. QUT Law Review, [S.l.], v. 18, n. 2, p. 163- 170, jan. 2019. ISSN 2201-7275. Available at: <https://lr.law.qut.edu.au/article/view/766>. Date accessed: 01 feb. 2021. doi: https://doi.org/10.5204/qutlr.v18i2.766.
Abstract Views
889
PDF(89KB) Views
559